Related Experiment Video
Updated: Aug 10, 2026
Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
Published on: March 26, 2015
Myelin mutants: model systems for the study of normal and abnormal myelination
1Dept of Veterinary Clinical Studies, University of Glasgow, Bearsden, Scotland. gvsa04@udcf.gla.ac.uk
Abstract:
Spontaneous mutations that perturb myelination occur in a range of species including man, and together with engineered mutations have been used to study disease, normal myelination and axon/glial inter-relationships. Only a minority of the currently defined mutations have an apparently simple pathogenesis due to lack of a functional protein. Mutations in the myelin basic protein gene lead to a lack of protein, resulting in changes in the structure of myelin, which can be rescued by transgenic complementation. The pathogenesis of autosomal dominant and X-linked mutations affecting either oligodendrocytes or Schwann cells is more complex. Point mutations may act in a dominant negative manner and gene dosage is clearly linked to phenotypic change. Mutations in regulatory genes, such as those encoding transcription factors, can also disturb myelination by selected cell types. Other less-well studied and unexpected consequences of myelin mutations, such as seizures in mutations affecting genes expressed in Schwann cells and axonal changes associated with dysmyelination, are also considered. With the major developments in gene mapping and cloning it is now relevant to study mutations in a variety of species with the real prospect of defining their molecular basis. Examples are given of unusual, but potentially useful, uncharacterized mutations in dog and bovine.
Insights
Spontaneous mutations impact myelination across species. Studying these genetic changes, from simple protein deficiencies to complex regulatory issues, aids understanding of neurological diseases and axon-glial interactions.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Myelination is crucial for nervous system function, involving complex interactions between axons and glial cells (oligodendrocytes and Schwann cells).
- Spontaneous and engineered mutations affecting myelination provide valuable models for studying neurological disorders and normal nervous system development.
Purpose of the Study:
- To review the diverse mechanisms underlying mutations that perturb myelination.
- To highlight the complexity of myelin gene mutations and their varied pathological consequences.
- To emphasize the utility of comparative genomics in understanding myelination defects.
Main Methods:
- Analysis of spontaneous and engineered mutations affecting myelin and associated cells across various species.
- Review of molecular pathogenesis, including protein deficiency, dominant-negative effects, gene dosage, and regulatory gene mutations.
- Consideration of unexpected phenotypes, such as seizures and axonal pathology.
Main Results:
- Mutations can result in simple protein loss (e.g., myelin basic protein) or complex pathogenesis involving dominant-negative effects and altered gene dosage.
- Regulatory gene mutations can selectively disrupt myelination in specific cell types.
- Myelin mutations can lead to unexpected phenotypes, including seizures and axonal damage.
Conclusions:
- Understanding the molecular basis of myelination mutations is advanced by studying diverse species.
- Comparative studies of mutations in model organisms and domestic animals offer insights into human neurological diseases.
- Further characterization of unstudied mutations may reveal novel mechanisms of myelination control and pathology.
